个人中心 - 老虎社区

jessicacaca

IP属地：未知

帖子 · 111帖子 · 111
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- jessicacacajessicacaca
  ·2021-09-07
  $Alibaba(BABA)$Please go up
  2,642 评论
  10
  分享
  举报
- jessicacacajessicacaca
  ·2021-09-05
  $Tencent Music(TME)$Can cry
  1,777 1
  2
  分享
  举报
- jessicacacajessicacaca
  ·2021-09-04
  $Tiger Brokers(TIGR)$gogoog
  1,814 评论
  3
  分享
  举报
- jessicacacajessicacaca
  ·2021-09-03
  $Tencent Music(TME)$please go up
  1,600 评论
  2
  分享
  举报
- jessicacacajessicacaca
  ·2021-09-02
  $Alibaba(BABA)$Please go up!
  1,943 1
  2
  分享
  举报
- jessicacacajessicacaca
  ·2021-08-30
  Go go!
  非常抱歉，此主贴已删除
  1,575 1
  3
  分享
  举报
- jessicacacajessicacaca
  ·2021-08-30
  $Tiger Brokers(TIGR)$Pkease go go!
  843 评论
  8
  分享
  举报
- jessicacacajessicacaca
  ·2021-08-29
  $Alibaba(BABA)$Go up!
  1,761 评论
  2
  分享
  举报
- jessicacacajessicacaca
  ·2021-08-28
  cool
  U.S. resumes supply of Lilly's COVID-19 antibody combo to some states
  Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID
  U.S. resumes supply of Lilly's COVID-19 antibody combo to some states
  1,056 评论
  5
  分享
  举报
- jessicacacajessicacaca
  ·2021-08-28
  $Exela Technologies, Inc.(XELA)$goooo
  2,174 1
  4
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3585036618849090","uuid":"3585036618849090","gmtCreate":1621942776918,"gmtModify":1624586642809,"name":"jessicacaca","pinyin":"jessicacaca","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":50,"headSize":3,"tweetSize":111,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.25%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":880126075,"gmtCreate":1631026172797,"gmtModify":1631883593974,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Please go up&nbsp;","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Please go up&nbsp;","text":"$Alibaba(BABA)$Please go up","images":[{"img":"https://static.tigerbbs.com/2aec2b035c0efb0bc39fdf72b9ec3e66","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/880126075","isVote":1,"tweetType":1,"viewCount":2642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":814897820,"gmtCreate":1630804171360,"gmtModify":1631885005726,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TME\">$Tencent Music(TME)$</a>Can cry","listText":"<a href=\"https://laohu8.com/S/TME\">$Tencent Music(TME)$</a>Can cry","text":"$Tencent Music(TME)$Can cry","images":[{"img":"https://static.tigerbbs.com/c097653a6156479b4bf747a46535285c","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/814897820","isVote":1,"tweetType":1,"viewCount":1777,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":814338232,"gmtCreate":1630760293226,"gmtModify":1631890963043,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>gogoog","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>gogoog","text":"$Tiger Brokers(TIGR)$gogoog","images":[{"img":"https://static.tigerbbs.com/1912afe4445644e96457361b2326bd17","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/814338232","isVote":1,"tweetType":1,"viewCount":1814,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":815864914,"gmtCreate":1630667288638,"gmtModify":1631885005749,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TME\">$Tencent Music(TME)$</a>please go up","listText":"<a href=\"https://laohu8.com/S/TME\">$Tencent Music(TME)$</a>please go up","text":"$Tencent Music(TME)$please go up","images":[{"img":"https://static.tigerbbs.com/07d87cc37cb36f0d2d18719ff4fdea97","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/815864914","isVote":1,"tweetType":1,"viewCount":1600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":812663885,"gmtCreate":1630583929347,"gmtModify":1631883610775,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Please go up!","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Please go up!","text":"$Alibaba(BABA)$Please go up!","images":[{"img":"https://static.tigerbbs.com/e0e7a332a461ee8076f757a984984dcc","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/812663885","isVote":1,"tweetType":1,"viewCount":1943,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":811506946,"gmtCreate":1630330791685,"gmtModify":1704958559638,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"Go go!","listText":"Go go!","text":"Go go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/811506946","repostId":"1182616475","repostType":4,"isVote":1,"tweetType":1,"viewCount":1575,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811508002,"gmtCreate":1630330748606,"gmtModify":1704958557905,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Pkease go go!","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Pkease go go!","text":"$Tiger Brokers(TIGR)$Pkease go go!","images":[{"img":"https://static.tigerbbs.com/49e3fbb0ddbc10b7b89cb5105aea681b","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/811508002","isVote":1,"tweetType":1,"viewCount":843,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":813879098,"gmtCreate":1630193125714,"gmtModify":1704956777820,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Go up!","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Go up!","text":"$Alibaba(BABA)$Go up!","images":[{"img":"https://static.tigerbbs.com/7293f1140fda0de29e4a3361419bdab7","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/813879098","isVote":1,"tweetType":1,"viewCount":1761,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":813909998,"gmtCreate":1630117429214,"gmtModify":1704956210889,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"cool","listText":"cool","text":"cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/813909998","repostId":"2162707824","repostType":4,"repost":{"id":"2162707824","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630104635,"share":"https://ttm.financial/m/news/2162707824?lang=&edition=full","pubTime":"2021-08-28 06:50","market":"us","language":"en","title":"U.S. resumes supply of Lilly's COVID-19 antibody combo to some states","url":"https://stock-news.laohu8.com/highlight/detail?id=2162707824","media":"Reuters","summary":"Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID","content":"<p>Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.</p>\n<p>The Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.</p>\n<p>With the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said</p>\n<p>Based on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.</p>\n<p>The department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.</p>\n<p>The supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.</p>\n<p>Regeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's</p>\n<p>sotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.</p>\n<p>Bamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. resumes supply of Lilly's COVID-19 antibody combo to some states</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. resumes supply of Lilly's COVID-19 antibody combo to some states\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-28 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.</p>\n<p>The Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.</p>\n<p>With the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said</p>\n<p>Based on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.</p>\n<p>The department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.</p>\n<p>The supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.</p>\n<p>Regeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's</p>\n<p>sotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.</p>\n<p>Bamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"REGN":"再生元制药公司","LLY":"礼来","VIR":"Vir Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162707824","content_text":"Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.\nThe Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.\nWith the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said\nBased on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.\nThe department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.\nThe supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.\nRegeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's\nsotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.\nBamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.","news_type":1,"symbols_score_info":{"LLY":0.9,"REGN":0.9,"VIR":0.9}},"isVote":1,"tweetType":1,"viewCount":1056,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813077233,"gmtCreate":1630117363522,"gmtModify":1704956209321,"author":{"id":"3585036618849090","authorId":"3585036618849090","name":"jessicacaca","avatar":"https://static.tigerbbs.com/a84f924c2b3db684c9b639330ac5f40c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585036618849090","authorIdStr":"3585036618849090"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>goooo","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>goooo","text":"$Exela Technologies, Inc.(XELA)$goooo","images":[{"img":"https://static.tigerbbs.com/603754722a546851b17af45571e12705","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/813077233","isVote":1,"tweetType":1,"viewCount":2174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}